Your browser doesn't support javascript.
COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs.
Rodriguez-Morales, Alfonso J; Sah, Ranjit; Millan-Oñate, Jose; Gonzalez, Angel; Montenegro-Idrogo, Juan J; Scherger, Sias; Franco-Paredes, Carlos; Henao-Martínez, Andrés F.
  • Rodriguez-Morales AJ; Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas, Belmonte, Pereira, Risaralda 660003, Colombia. Associate Editor, Therapeutic Advances in Infectious Disease.
  • Sah R; Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.
  • Millan-Oñate J; Adult Infectious Diseases, Clínica Imbanaco QuirónSalud, Cali, Valle del Cauca, Colombia.
  • Gonzalez A; Basic and Applied Microbiology Research Group (MICROBA), School of Microbiology, Universidad de Antioquia, Medellin, Colombia.
  • Montenegro-Idrogo JJ; Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru.
  • Scherger S; Division of Infectious Diseases, University of Colorado Denver School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.
  • Franco-Paredes C; Division of Infectious Diseases, University of Colorado Denver School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.
  • Henao-Martínez AF; Division of Infectious Diseases, University of Colorado Denver School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.
Ther Adv Infect Dis ; 8: 20499361211027065, 2021.
Article in English | MEDLINE | ID: covidwho-1282226

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Ther Adv Infect Dis Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Ther Adv Infect Dis Year: 2021 Document Type: Article